The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
5 marketed package NDCs · 1 active manufacturer
Most dispensed: 3 mg/.5mL · Injection, Solution · #4 syringes/carton / .5 ml in 1 syringe · 1.5 mg/.5mL · Injection, Solution · #4 syringes/carton / .5 ml in 1 syringe · .75 mg/.5mL · Injection, Solution · #4 syringes/carton / .5 ml in 1 syringe · 4.5 mg/.5mL · Injection, Solution · #4 syringes/carton / .5 ml in 1 syringe
Only one company currently supplies this market — there is no backup if it stumbles.
Every detected change for dulaglutide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in GLP-1 Receptor Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.